Publication:
Carbonic Anhydrase Inhibitors: In Vitro Inhibition of α Isoforms (HCA I, HCA II, BCA III, HCA IV) by Flavonoids

dc.authorscopusid58435133500
dc.authorscopusid55979838600
dc.authorscopusid23027537500
dc.authorscopusid23013520200
dc.authorscopusid7102904152
dc.contributor.authorEkinci, D.
dc.contributor.authorKaragoz, L.
dc.contributor.authorEkinci, D.
dc.contributor.authorŞentürk, M.
dc.contributor.authorSupuran, C.T.
dc.date.accessioned2020-06-21T14:06:08Z
dc.date.available2020-06-21T14:06:08Z
dc.date.issued2013
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ekinci] Derya, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Karagoz] Lütfi, Department of Chemistry, Yıldız Teknik Üniversitesi, Istanbul, Turkey; [Ekinci] Deniz, Department of Agricultural Biotechnology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şentürk] Murat, Department of Chemistry, Aǧrı İbrahim Çeçen Üniversitesi, Agri, Agri, Turkey; [Supuran] Claudiu T., Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Florence, FI, Italyen_US
dc.description.abstractA series of flavonoids, such as quercetin, catechin, apigenin, luteolin, morin, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA). The compounds were tested against four α-CA isozymes purified from human and bovine (hCA I, hCA II, bCA III, hCA IV) tissues. The four isozymes showed quite diverse inhibition profiles with these compounds. The flavonoids inhibited hCA I with KI-s in the range of 2.2-12.8 μM, hCA II with KI-s in the range of 0.74-6.2 μM, bCA III with KI-s in the range of 2.2-21.3 μM, and hCA IV with inhibition constants in the range of 4.4-15.7, with an esterase assay using 4-nitrophenyl acetate as substrate. Some simple phenols/sulfonamides were also investigated as standard inhibitors. The flavonoids incorporate phenol moieties which inhibit these CAs through a diverse, not yet determined inhibition mechanism, compared to classic inhibitors such as the sulfonamide/sulfamate ones. © 2013 Informa UK, Ltd.en_US
dc.identifier.doi10.3109/14756366.2011.643303
dc.identifier.endpage288en_US
dc.identifier.issn1475-6366
dc.identifier.issn1475-6374
dc.identifier.issue2en_US
dc.identifier.pmid22168126
dc.identifier.scopus2-s2.0-84879396682
dc.identifier.scopusqualityQ1
dc.identifier.startpage283en_US
dc.identifier.urihttps://doi.org/10.3109/14756366.2011.643303
dc.identifier.volume28en_US
dc.identifier.wosWOS:000314531000006
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherInforma Healthcareen_US
dc.relation.ispartofJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.journalJournal of Enzyme Inhibition and Medicinal Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCarbonic Anhydraseen_US
dc.subjectFlavonoiden_US
dc.subjectInhibitoren_US
dc.subjectPhenolen_US
dc.titleCarbonic Anhydrase Inhibitors: In Vitro Inhibition of α Isoforms (HCA I, HCA II, BCA III, HCA IV) by Flavonoidsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files